IMS Health — Stifel Fireside Presentation (November 2014)
9 slides from IMS Health's conference presentation, Nov 19, 2014
Slide 1: IMS Health
IMS Health Ron Bruehlman, SVP & CFO November 19th, 2014 IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 2: Legal
Legal Forward-Looking Statements This presentation includes “forward-looking statements.” The words “believes,” “expects,” “may,” “will” and similar expressions are intended to identify forward forward-looking looking statements, statements although not all forward forward-looking looking statements
Slide 3: Who We Are
Who We Are Mission • Leverage information and technology services to deliver intelligence and drive improved performance for a growing universe of healthcare customers globally History • 60+ years provider of mission-critical information to life sciences companies, deployed d l d in 100+ 00 countrie
Slide 4: Market Positioning
Market Positioning $75bn* Total addressable market $5bn $45bn $25bn 2010 2014 Core offerings Expanded offerings Expanded customers • Sales and • Workflow analytics • Consumer Health / OTC medical audits • Real world evidence • Medical devices • Promotional audits • Clinical trial optimization soluti
Slide 5: Operational Excellence
Operational Excellence 2010 2014 -2% 2% CAGR +6% CAGR Revenue growth 2007-2010 2010-LTM 2014 -6% CAGR +10% CAGR EBITDA growth 2007-2010 2010-LTM 2014 27% 33% EBITDA margin 2009 LTM 2014 Customer-facing resources <33% >50% Offshore delivery resources <250 >2,500 , Development capabilities >70% outsou
Slide 6: Revenue
Revenue $mm 2 637 2,637 Revenue Recurring 2,162 CAGR model revenue 1,101 +12% • Project Project-based based ~35% Technology Services 714 • Multi-year service arrangements • Subscription- based • SaaS license Information 1,448 1,536 +2% • Subscription- ~90% based • Annual renewals, evergreen or multi
Slide 7: Offerings
Offerings Integrated solutions Information Technology services National audits Technology and applications Regional sales audits Workflow analytics Non biopharma audits Real world evidence Consulting services Note: Audits = Sales, volume, visits, diagnoses, etc. IMS Health Confidential. 7 (c) 2014 I
Slide 8: Geographic Growth Profile
Geographic Growth Profile 2010 – LTM 2014 CAGR % 5% Revenue 12% Revenue Growth Growth developed markets emerging markets 36% 5% 3% 19% 5% 15% 2014 LTM is through September 2014. IMS Health Confidential. 8 (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 9: IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.
IMS Health Confidential. 9 (c) 2014 IMS Health Incorporated. All Rights Reserved.
IMS Health — Stifel Fireside Presentation (November 2014) on 6ix